Offshore Buyer Has Sigma Pharmaceuticals in Its Sights

South Africa’s Aspen Pharma has made an opportunistic bid for the troubled Sigma Pharmaceuticals, which has suffered a 60 per cent plunge in the value of its shares since reporting a $389 million loss.
The Australian